{"id":"W2541115330","doi":"10.1016/j.jval.2016.09.996","title":"Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mirabegron; Tolterodine; Overactive bladder; Oxybutynin; Medicine; Solifenacin; Urology; Discontinuation; Persistence (discontinuity); Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004640584,0.0007328315,0.001447221,0.001267616,0.0002548635,0.002032096,0.0008317842,0.002087168,0.002937953],"category_scores_gemma":[0.02834622,0.0006900353,0.002443328,0.001516038,0.0008564542,0.001475602,0.001511179,0.001856792,0.0002506779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007899312,"about_ca_system_score_gemma":0.001943072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0896553,"about_ca_topic_score_gemma":0.05007699,"domain_scores_codex":[0.9954977,0.003082555,0.0004113583,0.0002997891,0.0003031717,0.0004054443],"domain_scores_gemma":[0.9790558,0.01726886,0.002097808,0.000307433,0.000647373,0.000622653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.05828803,0.0007578906,0.338007,0.005510715,0.006572782,0.001982191,0.000709246,0.4632617,0.001861044,0.009410866,0.008739487,0.1048991],"study_design_scores_gemma":[0.008243028,0.01535348,0.6892914,0.002937859,0.008751404,0.003426584,0.003507168,0.2437935,0.002359515,0.008278669,0.01354705,0.0005103414],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9644621,0.02296577,0.001418593,0.003101138,0.0001253231,0.000162848,0.004717304,0.00002275534,0.003024085],"genre_scores_gemma":[0.9959877,0.001920761,0.0005559746,0.0002027821,0.00002585452,0.0000401778,0.0008815386,0.000004350979,0.0003808363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0896553,"threshold_uncertainty_score":0.1782669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2324430650180934,"score_gpt":0.4506524978750892,"score_spread":0.2182094328569957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}